Tsoukas, M. A. “Glucagon-Like Peptide-1 Receptor Agonist Treatment in Type 1 Diabetes: A Review of Current Evidence and Rationale for Use”. Canadian Diabetes & Endocrinology Today, vol. 1, no. 3, Oct. 2023, pp. 21–26, doi:10.58931/cdet.2023.1318.